Ver registro no DEDALUS
Exportar registro bibliográfico



Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer (2017)

  • Authors:
  • USP Schools: FOB; FO; FOB
  • DOI: 10.1007/s00784-016-1956-3
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00784-016-1956-3 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007/s00784-016-1956-3 (Fonte: Unpaywall API)

    Título do periódico: Clinical Oral Investigations

    ISSN: 1432-6981,1436-3771

      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Clinical Oral Investigations

    ISSN: 1432-6981

    Citescore - 2017: 2.25

    SJR - 2017: 0.986

    SNIP - 2017: 1.173

  • How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ASSAO, Agnes; NONOGAKI, Suely; LAURIS, José Roberto Pereira; et al. Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer. Clinical Oral Investigations, Heidelberg, Springer, v. 21, n. 5, p. 1647-1657, 2017. Disponível em: < > DOI: 10.1007/s00784-016-1956-3.
    • APA

      Assao, A., Nonogaki, S., Lauris, J. R. P., Carvalho, A. L., Pinto, C. A. L., Soares, F. A., et al. (2017). Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer. Clinical Oral Investigations, 21( 5), 1647-1657. doi:10.1007/s00784-016-1956-3
    • NLM

      Assao A, Nonogaki S, Lauris JRP, Carvalho AL, Pinto CAL, Soares FA, Kowalski LP, Oliveira DT. Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer [Internet]. Clinical Oral Investigations. 2017 ; 21( 5): 1647-1657.Available from:
    • Vancouver

      Assao A, Nonogaki S, Lauris JRP, Carvalho AL, Pinto CAL, Soares FA, Kowalski LP, Oliveira DT. Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer [Internet]. Clinical Oral Investigations. 2017 ; 21( 5): 1647-1657.Available from:

    Referências citadas na obra
    Yuan P, Temam S, El-Naggar A, Zhou X, Liu DD, Lee JJ, Mao L (2006) Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer 107(3):563–569. doi: 10.1002/cncr.22061
    Vormittag L, Thurnher D, Geleff S, Pammer J, Heiduschka G, Brunner M, Grasl M, Erovic BM (2009) Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy. Int J Radiat Oncol Biol Phys 73(3):913–918. doi: 10.1016/j.ijrobp.2008.10.040
    Kreppel M, Scheer M, Drebber U, Ritter L, Zoller JE (2010) Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations. Virchows Arch 456(5):473–482. doi: 10.1007/s00428-010-0915-7
    Funayama A, Cheng J, Maruyama S, Yamazaki M, Kobayashi T, Syafriadi M, Kundu S, Shingaki S, Saito C, Saku T (2011) Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas. Pathobiology 78(3):171–180. doi: 10.1159/000324926
    Huber GF, Fritzsche FR, Zullig L, Storz M, Graf N, Haerle SK, Jochum W, Stoeckli SJ, Moch H (2011) Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx. Int J Cancer 129(6):1404–1409. doi: 10.1002/ijc.25795
    Kreppel M, Drebber U, Wedemeyer I, Eich HT, Backhaus T, Zoller JE, Scheer M (2011) Podoplanin expression predicts prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy. Oral Oncol 47(9):873–878. doi: 10.1016/j.oraloncology.2011.06.508
    Bartuli FN, Luciani F, Caddeo F, Compagni S, Piva P, Ottria L, Arcuri C (2012) Podoplanin in the development and progression of oral cavity cancer: a preliminary study. Oral Implantol (Rome) 5(2–3):33–41
    dos Santos Almeida A, Oliveira DT, Pereira MC, Faustino SE, Nonogaki S, Carvalho AL, Kowalski LP (2013) Podoplanin and VEGF-C immunoexpression in oral squamous cell carcinomas: prognostic significance. Anticancer Res 33(9):3969–3976
    Foschini MP, Leonardi E, Eusebi LH, Farnedi A, Poli T, Tarsitano A, Cocchi R, Marchetti C, Gentile L, Sesenna E, Marucci G, Montebugnoli L (2013) Podoplanin and E-cadherin expression in preoperative incisional biopsies of oral squamous cell carcinoma is related to lymph node metastases. Int J Surg Pathol 21(2):133–141. doi: 10.1177/1066896912471851
    Wicki A, Christofori G (2007) The potential role of podoplanin in tumour invasion. Br J Cancer 96(1):1–5. doi: 10.1038/sj.bjc.6603518
    Martin-Villar E, Megias D, Castel S, Yurrita MM, Vilaro S, Quintanilla M (2006) Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J Cell Sci 119 (Pt 21):4541–4553. doi: 10.1242/jcs.03218
    Madan R, Brandwein-Gensler M, Schlecht NF, Elias K, Gorbovitsky E, Belbin TJ, Mahmood R, Breining D, Qian H, Childs G, Locker J, Smith R, Haigentz M, Jr., Gunn-Moore F, Prystowsky MB (2006) Differential tissue and subcellular expression of ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma. Head Neck 28 (11):1018–1027. doi: 10.1002/hed.20435
    Arpin M, Chirivino D, Naba A, Zwaenepoel I (2011) Emerging role for ERM proteins in cell adhesion and migration. Cell Adhes Migr 5(2):199–206
    McClatchey AI (2014) ERM proteins at a glance. J Cell Sci 127 (Pt 15):3199–3204. doi: 10.1242/jcs.098343
    Renart J, Carrasco-Ramirez P, Fernandez-Munoz B, Martin-Villar E, Montero L, Yurrita MM, Quintanilla M (2015) New insights into the role of podoplanin in epithelial-mesenchymal transition. Int Rev Cell Mol Biol 317:185–239. doi: 10.1016/bs.ircmb.2015.01.009
    Martin-Villar E, Borda-d'Agua B, Carrasco-Ramirez P, Renart J, Parsons M, Quintanilla M, Jones GE (2014) Podoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stability. Oncogene 0. doi: 10.1038/onc.2014.388
    Fernandez-Munoz B, Yurrita MM, Martin-Villar E, Carrasco-Ramirez P, Megias D, Renart J, Quintanilla M (2011) The transmembrane domain of podoplanin is required for its association with lipid rafts and the induction of epithelial-mesenchymal transition. Int J Biochem Cell Biol 43(6):886–896. doi: 10.1016/j.biocel.2011.02.010
    Matsui K, Breitender-Geleff S, Soleiman A, Kowalski H, Kerjaschki D (1999) Podoplanin, a novel 43-kDa membrane protein, controls the shape of podocytes. Nephrol Dial Transplant 14 Suppl 1:9–11
    Martin-Villar E, Scholl FG, Gamallo C, Yurrita MM, Munoz-Guerra M, Cruces J, Quintanilla M (2005) Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int J Cancer 113(6):899–910. doi: 10.1002/ijc.20656
    Ma L, Liu YP, Zhang XH, Geng CZ, Li ZH (2013) Relationship of RhoA signaling activity with ezrin expression and its significance in the prognosis for breast cancer patients. Chin Med J 126(2):242–247
    Saito S, Yamamoto H, Mukaisho K, Sato S, Higo T, Hattori T, Yamamoto G, Sugihara H (2013) Mechanisms underlying cancer progression caused by ezrin overexpression in tongue squamous cell carcinoma. PLoS One 8(1):e54881. doi: 10.1371/journal.pone.0054881
    Wu G, Sun X, Yuan H, Hu M (2013) Ezrin gene expression and protein production in the CD44(+) subpopulation of SCC-9 cells in a malignant oral cancer cell line in vitro. J Oral Maxillofac Surg 71(3):e151–e157. doi: 10.1016/j.joms.2012.11.011
    Mhawech-Fauceglia P, Dulguerov P, Beck A, Bonet M, Allal AS (2007) Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy. J Clin Pathol 60(2):185–189. doi: 10.1136/jcp.2006.036624
    Schlecht NF, Brandwein-Gensler M, Smith RV, Kawachi N, Broughel D, Lin J, Keller CE, Reynolds PA, Gunn-Moore FJ, Harris T, Childs G, Belbin TJ, Prystowsky MB (2012) Cytoplasmic ezrin and moesin correlate with poor survival in head and neck squamous cell carcinoma. Head Neck Pathol 6(2):232–243. doi: 10.1007/s12105-011-0328-1
    Sobin L, Gospodarowicz MK, Wittekind C (2009) International union against cancer (UICC): TNM classification of malignant tumours, 7th ed. Willey, New York
    Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, Genden E, Urken ML, Wang BY (2005) Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29(2):167–178
    Faustino SE, Oliveira DT, Nonogaki S, Landman G, Carvalho AL, Kowalski LP (2008) Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma. Int J Oral Maxillofac Surg 37(4):372–378. doi: 10.1016/j.ijom.2007.11.021
    Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G (2006) Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9(4):261–272. doi: 10.1016/j.ccr.2006.03.010
    Garcia AS, Tjioe KC, Nonogaki S, Soares FA, Soares CT, Lauris JRP, Oliveira DT (2014) Ezrin and podoplanin expressions are associated in invasion front of lip cancer. Head Neck Oncol 03(06):8
    Vukadinovic M, Jezdic Z, Petrovic M, Medenica LM, Lens M (2007) Surgical management of squamous cell carcinoma of the lip: analysis of a 10-year experience in 223 patients. J Oral Maxillofac Surg 65(4):675–679. doi: 10.1016/j.joms.2006.03.054
    Gutierrez-Pascual M, Vicente-Martin FJ, Fernandez-Alvarez JG, Martin-Lopez R, Pinedo-Moraleda F, Lopez-Estebaranz JL (2012) Squamous cell carcinoma of the lip. A retrospective study of 146 patients. J Eur Acad Dermatol Venereol 26(9):1116–1121. doi: 10.1111/j.1468-3083.2011.04227.x
    Santos HB, Silva AL, Cavalcante LH, Alves PM, Godoy GP, Nonaka CF (2014) Histopathological grading systems and their relationship with clinical parameters in lower lip squamous cell carcinoma. Int J Oral Maxillofac Surg 43(5):539–545. doi: 10.1016/j.ijom.2013.10.021
    Cueni LN, Hegyi I, Shin JW, Albinger-Hegyi A, Gruber S, Kunstfeld R, Moch H, Detmar M (2010) Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin. Am J Pathol 177(2):1004–1016. doi: 10.2353/ajpath.2010.090703
    Inoue H, Miyazaki Y, Kikuchi K, Yoshida N, Ide F, Ohmori Y, Tomomura A, Sakashita H, Kusama K (2012) Podoplanin expression during dysplasia-carcinoma sequence in the oral cavity. Tumour Biol 33(1):183–194. doi: 10.1007/s13277-011-0261-7
    Tsuneki M, Maruyama S, Yamazaki M, Cheng J, Saku T (2012) Podoplanin expression profiles characteristic of odontogenic tumor-specific tissue architectures. Pathol Res Pract 208(3):140–146. doi: 10.1016/j.prp.2011.12.016
    de Vicente JC, Santamarta TR, Rodrigo JP, Garcia-Pedrero JM, Allonca E, Blanco-Lorenzo V (2015) Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival. Virchows Arch. doi: 10.1007/s00428-015-1746-3
    Clucas J, Valderrama F (2015) ERM proteins in cancer progression. J Cell Sci 128(6):1253. doi: 10.1242/jcs.170027
    Abraham MT, Kuriakose MA, Sacks PG, Yee H, Chiriboga L, Bearer EL, Delacure MD (2001) Motility-related proteins as markers for head and neck squamous cell cancer. Laryngoscope 111(7):1285–1289. doi: 10.1097/00005537-200107000-00027
    Li YY, Zhou CX, Gao Y (2015) Podoplanin promotes the invasion of oral squamous cell carcinoma in coordination with MT1-MMP and Rho GTPases. Am J Cancer Res 5(2):514–529